Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 8, 1998, Pages 1199-1202

  Nilsson, Jan ^a   Jovinge, Stefan ^a   Niemann, Audrey ^a   Reneland, Richard ^b   Lithell, Hans ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diabetes; HDL; Insulin resistance; Triglycerides; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGED; ARTICLE; AUTOPHOSPHORYLATION; BODY WEIGHT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOREGULATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

EID: 0031867918     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.8.1199     Document Type: Article

References (21)

1. Rouzer CA, Cerami A. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol 1980;2:31-38.
2. Old LJ. Tumor necrosis factor (TNF). Science. 1985;230:630-633.
3. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol. 1989;7:625-655.
4. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271-1278.
5. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
6. Hotamisligil GS, Murray DL, Choy LN, Spiegelman B. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994;91:4854-4858.
7. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor α-induced phosphorylation of the insulin receptor substrate-1 (IRS-1). J Biol Chem. 1995;270:23780-23784.
8. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest. 1994;94:1543-1549.
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111-2119.
11. Saghizadeh M, Ong JM, Garvey WT, Henry R, Kern PA. The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest. 1996;97:1111-1116.
12. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473-486.
13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;273: E214-E223.
14. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 1991;11: 1192-1203.
15. Jovinge S, Hamsten A, Tornvall P, Proudler A, Båvenholm P, Ericsson C-G, Godsland I, de Faire U, Nilsson J. Evidence for a role of tumor necrosis factor α in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism. 1998;47:113-118.
16. Engelberts I, Stephens S, Francot GJM, van der Linden CJ, Buurman WA. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet. 1991;338: 515-516.
17. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promotor is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun. 1995;211:833-839.
18. Feingold KR, Serio MK, Adi S, Moser AH, Grünfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology. 1989;124:2336-2342.
19. Memon RA, Grünfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effect of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993;132:2246-2253.
20. Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. Biochemistry. 1987;101:331-338.
21. Saxena U, Witte LD, Goldberg IJ. Tumor necrosis factor induced release of endothelial cell lipoprotein lipase. Arteriosclerosis. 1990;10:470-476.